Department of Surgery, Seoul National University Hospital
Seoul, South Korea
NCT Number: NCT01134276
Preoperative biliary drainage methods include percutaneous transhepatic biliary drainage (PTBD), endoscopic nasobiliary drainage (ENBD), and endoscopic retrograde biliary drainage (ERBD). Endoscopic biliary drainages often induce peritumoral inflammation and it increase difficulties in determining a proper resection margin. The purpose of this study is to compare the clinicopathological outcomes according to the methods of preoperative biliary drainage in periampullary cancers causing obstructive jaundice, and to find out a proper biliary drainage method.
Looking for future studies?
Notify Me20 year–85 year
All sexes
Interventional
Not applicable
Seoul, South Korea
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
biliary drainage via PTBD or ERBD/ENBD
Time frame: within 120 days after drainage
at least 90 days after operation change in serum bilirubin cholangitis blood test (complete blood cell count, liver function test, CRP)
Time frame: within 14 days after drainage
Effect of reducing serum total bilirubin after drainage in terms of Daily diminution of bilirubin(mg/dL/day)
Time frame: during hospital stay for biliary drainage procedure
Total hospital cost during admission after Biliary Drainage in US dollars
Seoul National University Hospital
Other
Prospective Study on the Comparison Between the Clinicopathological Outcomes According to the Methods of Preoperative Biliary Drainage in Periampullary Cancers Causing Obstructive Jaundice
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04763642
Ampulla of Vater Cancer, Bile Duct Cancer
Krasnodar, Krasnodarskiy Kray, Russia
View Trial DetailsNCT04853017
Adenocarcinoma, Adnexal Diseases
Duarte, California, United States
View Trial DetailsNCT02375880
Adenocarcinoma, Bile Duct Cancer
Los Angeles, California, United States
View Trial DetailsNCT03058289
Bile Duct Cancer, Bile Duct Diseases
Los Angeles, California, United States
View Trial Details